RUBY-I: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection With Severe Renal Impairment or End-Stage Renal Disease

Press/Media: Press / Media

PeriodNov 16 2016

Media coverage

1

Media coverage

  • TitleRUBY-I: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection With Severe Renal Impairment or End-Stage Renal Disease
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date11/16/16
    PersonsEric J Lawitz